MS can gradually affect daily life even without relapses, so regular check-ins should look beyond walking.
This article is a practical guide for spotting disability progression, meaning a lasting increase in difficulty doing things. It explains that these changes can happen even when treatment is doing a good job of preventing relapses, or periods of new or worsening symptoms. The usual disability score focuses heavily on walking, so it may miss changes in other parts of daily life. The authors suggest a step-by-step way for neurologists to check whether a person’s abilities are stable or changing. They say this approach could help care teams recognize progression sooner and consider appropriate care.
If you have MS, tell your care team about lasting changes in what you can do, even if you have not had a relapse. A walking test is only one piece of the puzzle, like checking a car’s tires but not its brakes. Before visits, write down tasks that have become harder and when you first noticed the change. Caregivers can help by sharing changes they notice in everyday routines. Neurologists may use these details alongside their exams to build a fuller picture and discuss next steps.
This is a proposed guide, not a study showing that its steps improve patient outcomes. The abstract does not list every check in the approach, so patients cannot use it as a self-test. A new or worsening problem can have more than one cause, so discuss it with your care team rather than assuming it is MS progression.
AI-generated summary — for informational purposes only, not medical advice
1/1/2027
A Korean study found higher levels of one Epstein-Barr virus antibody in people with MS. Learn why t
Read More1/1/2027
Explore a study linking a gene change to immune cells in spinal fluid in MS, what those cells may sa
Read More11/3/2026
Sexual health concerns are common with MS. Learn how symptoms and pregnancy plans may affect intimac
Read More11/2/2026
A case report links longer gaps between MS infusions with low drug levels and antibodies. Learn what
Read More11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.